MoneyWorks4Me

Amrutanjan Health Care informs about quarterly statement of investor complaints

08 Apr 2016 Evaluate

Amrutanjan Health Care has informed about Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended March 31, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1744.35
Dr. Reddys Labs. 1238.05
Cipla 1324.00
Lupin 1931.40
Zydus Lifesciences 1111.00
View more..